Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy C Mottram

Showing results (121-130 of 183) with videos related to

Pageof 19
Sort By:
Plos Neglected Tropical Diseases|November 27, 2013
Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferaseAlex P McLatchie, Hollie Burrell-Saward, Elmarie Myburgh, et al.
Advances in Parasitology|December 6, 2011
Trichomonas vaginalis pathobiology new insights from the genome sequenceRobert P Hirt, Natalia de Miguel, Sirintra Nakjang, et al.
Nature Communications|January 2, 2025
TransLeish: Identification of membrane transporters essential for survival of intracellular Leishmania parasites in a systematic gene deletion screenAndreia Albuquerque-Wendt, Ciaran McCoy, Rachel Neish, et al.
Plos Pathogens|June 17, 2020
Essential roles for deubiquitination in Leishmania life cycle progressionAndreas Damianou, Rebecca J Burge, Carolina M C Catta-Preta, et al.
Plos Neglected Tropical Diseases|June 21, 2021
Role of the inhibitor of serine peptidase 2 (ISP2) of Trypanosoma brucei rhodesiense in parasite virulence and modulation of the inflammatory responses of the hostDavid Jessula Levy, Amy Goundry, Raquel S S Laires, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Dipeptidyl alpha-fluorovinyl Michael acceptors: synthesis and activity against cysteine proteasesKoen Steert, Ibrahim El-Sayed, Pieter Van der Veken, et al.
Plos Neglected Tropical Diseases|April 13, 2011
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinaseRoderick G Walker, Graeme Thomson, Kirk Malone, et al.
ACS Infectious Diseases|October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug DiscoveryCatherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
Chemmedchem|August 28, 2010
α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPBKoen Steert, Maya Berg, Jeremy C Mottram, et al.
The Journal of Biological Chemistry|March 5, 2016
Crystal Structure and Activity Studies of the C11 Cysteine Peptidase from Parabacteroides merdae in the Human Gut MicrobiomeKaren McLuskey, Jaspreet S Grewal, Debanu Das, et al.
Pageof 19

Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Plos Neglected Tropical Diseases|November 27, 2013
Highly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferaseAlex P McLatchie, Hollie Burrell-Saward, Elmarie Myburgh, et al.
Advances in Parasitology|December 6, 2011
Trichomonas vaginalis pathobiology new insights from the genome sequenceRobert P Hirt, Natalia de Miguel, Sirintra Nakjang, et al.
Nature Communications|January 2, 2025
TransLeish: Identification of membrane transporters essential for survival of intracellular Leishmania parasites in a systematic gene deletion screenAndreia Albuquerque-Wendt, Ciaran McCoy, Rachel Neish, et al.
Plos Pathogens|June 17, 2020
Essential roles for deubiquitination in Leishmania life cycle progressionAndreas Damianou, Rebecca J Burge, Carolina M C Catta-Preta, et al.
Plos Neglected Tropical Diseases|June 21, 2021
Role of the inhibitor of serine peptidase 2 (ISP2) of Trypanosoma brucei rhodesiense in parasite virulence and modulation of the inflammatory responses of the hostDavid Jessula Levy, Amy Goundry, Raquel S S Laires, et al.
Bioorganic & Medicinal Chemistry Letters|October 16, 2007
Dipeptidyl alpha-fluorovinyl Michael acceptors: synthesis and activity against cysteine proteasesKoen Steert, Ibrahim El-Sayed, Pieter Van der Veken, et al.
Plos Neglected Tropical Diseases|April 13, 2011
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinaseRoderick G Walker, Graeme Thomson, Kirk Malone, et al.
ACS Infectious Diseases|October 31, 2023
Bromodomain Factor 5 as a Target for Antileishmanial Drug DiscoveryCatherine N Russell, Jennifer L Carter, Juliet M Borgia, et al.
Chemmedchem|August 28, 2010
α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPBKoen Steert, Maya Berg, Jeremy C Mottram, et al.
The Journal of Biological Chemistry|March 5, 2016
Crystal Structure and Activity Studies of the C11 Cysteine Peptidase from Parabacteroides merdae in the Human Gut MicrobiomeKaren McLuskey, Jaspreet S Grewal, Debanu Das, et al.
Pageof 19